Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 5/20 | 0.53 |
| ▸ | MDM4 | O15151 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.46 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31168844 | 0.92 | MDM2 (0.46) | MDM2MDM4TP53ALDH1A1ALOX15 | |
| SCHEMBL22444667 | 0.89 | MDM2 (0.53) | MDM2MDM4TP53CASP3SLC17A5 | |
| SCHEMBL29557307 | 0.89 | MDM4 (0.52) | MDM2MDM4TP53ALDH1A1CASP3 | |
| SCHEMBL22444637 | 0.89 | MDM4 (0.52) | MDM2MDM4TP53ALDH1A1CASP3 | |
| SCHEMBL17054258 | 0.89 | MDM4 (0.52) | MDM2MDM4TP53ALDH1A1CASP3 | |
| SCHEMBL29855217 | 0.89 | MDM4 (0.52) | MDM2MDM4TP53ALDH1A1CASP3 | |
| SCHEMBL25259836 | 0.87 | MDM2 (0.53) | MDM2MDM4TP53CASP3SLC17A5 | |
| SCHEMBL25259834 | 0.87 | MDM2 (0.53) | MDM2MDM4TP53CASP3SLC17A5 | |
| SCHEMBL13928511 | 0.87 | MDM2 (0.47) | MDM2MDM4TP53ALDH1A1ALOX15 | |
| SCHEMBL233300 | 0.87 | MDM2 (0.47) | MDM2MDM4TP53ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107423-A1 | ORAL PEPTIDES AND USES THEREOF FOR WEIGHT LOSS, WEIGHT MAINTENANCE, AND MANAGEMENT OF METABOLIC CONDITIONS | METSERA, INC. (US) | 2026-05-21 | — | — | WO | disclosed |